P6133 10X 0M 5pF 10MΩ 2 13 Passivo Sonda Accessori Tektronix N 6YwHqH at bayudiatmika.com
P6133 10X 0M 5pF 10MΩ 2 13 Passivo Sonda Accessori Tektronix N 6YwHqH

P6133 10X 0M 5pF 10MΩ 2 13 Passivo Sonda Accessori Tektronix N 6YwHqH

Tektronix 5pF Passivo Accessori 13 10MΩ 0M 10X Sonda N P6133 2

After hematopoietic cell transplant (HCT) the body’s immune system is severely compromised. As a result, these patients are especially vulnerable to infectious diseases. Infections for which immunocompetent persons can normally mount a sufficient immune response become potentially very serious. One such pathogen HCT recipients are vulnerable to is parainfluenza virus (PIV), which can precipitate lower respiratory tract disease (LRTD), a condition that can often be fatal.

Reported mortality rates from LRTD range from 13% to 63%, although the cause for this variability remains a mystery. VIDD scientists set out to delineate the reasons behind such inconsistency. The study, carried out by VIDD Research Associate Sachiko Seo, Affiliate Investigator Angela Campbell, Affiliate Staff Scientist Jane Kuypers, Affiliate Investigator Janet Englund, and Member Michael Boeckh, included 544 individuals who had undergone HCT at the Fred Hutch between 1990 and 2011 and had confirmed PIV infection. This retrospective cohort study evaluated clinical course and survival rates of patients with LRTD, which the investigators separated into 3 categories based on clinical manifestation at diagnosis: ‘Possible,’ ‘Probable’ and ‘Proven’ LRTD. They also compared these patients to those with the less severe PIV disease upper respiratory tract illness (URTI).

The overall survival rates over 90 days for patients with URTI and LRTD were 91% and 62%, respectively
(P < .001) (Figure, top graph). When the authors categorized LRTD into Possible, Probable or Proven, they uncovered drastic differences in disease morbidity and mortality. The survival rates for Possible, Probable and Proven LRTD were 87%, 58% and 45%, respectively        (P < .001) (Figure, bottom graph). This means Proven LRTD was almost twice as deadly when compared to Possible LRTD. A similar trend was seen when looking specifically at predicted pulmonary death by day 90 post PIV infection, as the likelihood was approximately 30% for total LRTD; 10-fold higher than for URTI (3%). Again, splitting LRTD into the three groupings showed a range of fatality rates from approximately 6% (Possible) to 44% (Proven). 

To date, it is not standard practice to clinically diagnose LRTD patients to one of these 3 categories. This study exemplifies the need to delineate LRTD into subgroups for proper diagnosis of and treatment for this disease as well as inform clinical studies of the epidemiology and clinical trials investigating new treatments for PIV.

 


Seo, S, Xie H, Campbell AP, Kuypers JM, Leisenring WM, Englund JA, Boeckh M. Parainfluenza Virus Lower Respiratory Tract Disease after Hematopoietic Cell Transplantation: Viral Detection in the Lung Predicts Outcome. Clin Infect Dis. Apr 2014.
Full-text Article:  http://scholars.fhcrc.org/3460/
PubMed Record: http://www.ncbi.nlm.nih.gov/pubmed/24599766?otool=fhcrclib

Accessori N Tektronix 13 P6133 Sonda 0M 10X Passivo 10MΩ 5pF 2  

 

Presto Jumbo 12 Metal Pentel ZL31 Pen Point Correction W Tip of Fine Box apvwBx
123522747576
Seller assumes all responsibility for this listing.